Tricyclic-cyclic amines as novel cholinesterase inhibitors
申请人:Pfizer Inc.
公开号:US05428043A1
公开(公告)日:1995-06-27
Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6,R.sup.11, R.sup.12, R.sup.13, E, G, X and P are as defined below. The compounds of formula I are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
Tricyclic amines as novel cholinesterase inhibitors
申请人:PFIZER INC.
公开号:EP0441517A2
公开(公告)日:1991-08-14
Compounds of the formula:-
wherein P is
Ring A is benzo, thieno, pyrido, pyrazino, pyrimido, furano, selenolo or pyrrolo; and R¹ to R¹³, E, G, L, M, X and n have the meanings stated in the text.
The compounds are cholinesterase inhibitors useful in the treatment of dementia and Alzheimer's disease.
式中的化合物: -
其中 P 是
环 A 是苯并、噻吩并、吡啶并、吡嗪并、嘧啶并、呋喃并、硒并或吡咯并;以及 R¹至 R¹³、E、G、L、M、X 和 n 具有文中所述的含义。
这些化合物是胆碱酯酶抑制剂,可用于治疗痴呆症和阿尔茨海默病。
Meyer,R.; Lueders, Justus Liebigs Annalen der Chemie, 1918, vol. 415, p. 31,32
作者:Meyer,R.、Lueders
DOI:——
日期:——
Alkhathlan, Hamad Z.; Al-Lohedan, Hamad A., Journal of Chemical Research, Miniprint, 1995, # 1, p. 201 - 220
作者:Alkhathlan, Hamad Z.、Al-Lohedan, Hamad A.
DOI:——
日期:——
Betrabet; Chakravarti, Journal of the Indian Chemical Society, 1930, vol. 7, p. 191,197